Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT00408070 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Did not meet accrual goals.

Conditions

Ovarian Cancer
Peritoneal Cancer
Fallopian Tube Cancer
Stage 3 Cancer
Stage 4 Cancer

Interventions

DRUG: Bevacizumab
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

UConn Health

Collaborators

[object Object]